April 17-18, 2019
Boston, USA





AXOL Bioscience: iPSC-derived microglia


Innovation Partner
AXOL’s hiPSC-derived Microglia provide a reproducible, physiologically-relevant model in an easy-to-use, assay-ready format for investigating neuroglia involvement in neurodegeneration and neurodevelopment. This homogenous and reproducible population of iPSC-derived Microglia exhibit physiologically relevant functionality, are highly phagocytic and produce cytokines in response to pathogens. They also express the microglia-specific marker TMEM119 along with myeloid markers TREM2 and IBA-1, making these iPSC-derived Microglia suitable models for investigating neuroinflammation in Alzheimer’s disease, multiple sclerosis and Parkinson’s disease.